ZOCCHI, CHIARA
 Distribuzione geografica
Continente #
AS - Asia 1.636
NA - Nord America 1.630
EU - Europa 1.338
SA - Sud America 163
AF - Africa 26
OC - Oceania 16
Totale 4.809
Nazione #
US - Stati Uniti d'America 1.589
RU - Federazione Russa 532
SG - Singapore 483
CN - Cina 430
HK - Hong Kong 276
IT - Italia 193
PL - Polonia 138
KR - Corea 137
BR - Brasile 136
VN - Vietnam 133
IE - Irlanda 95
DE - Germania 82
SE - Svezia 77
FI - Finlandia 60
IN - India 52
FR - Francia 40
GB - Regno Unito 39
JO - Giordania 30
BD - Bangladesh 23
CA - Canada 21
NL - Olanda 18
AU - Australia 16
ID - Indonesia 16
UA - Ucraina 15
AR - Argentina 14
JP - Giappone 14
CH - Svizzera 13
ES - Italia 13
TR - Turchia 13
MX - Messico 12
NG - Nigeria 7
ZA - Sudafrica 5
CI - Costa d'Avorio 4
IQ - Iraq 4
PK - Pakistan 4
PT - Portogallo 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BJ - Benin 3
CO - Colombia 3
EC - Ecuador 3
LT - Lituania 3
NI - Nicaragua 3
AT - Austria 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
KZ - Kazakistan 2
LU - Lussemburgo 2
OM - Oman 2
PE - Perù 2
PH - Filippine 2
TW - Taiwan 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BW - Botswana 1
BY - Bielorussia 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
EG - Egitto 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
KE - Kenya 1
MA - Marocco 1
MU - Mauritius 1
MY - Malesia 1
NO - Norvegia 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 4.809
Città #
Santa Clara 411
Singapore 365
Hong Kong 260
Ashburn 242
Hefei 149
Seoul 137
Warsaw 132
Dublin 95
San Jose 92
Chandler 71
Beijing 56
Fairfield 53
Munich 47
Ho Chi Minh City 43
Los Angeles 43
Florence 40
New York 40
Buffalo 37
Hanoi 35
Helsinki 28
Lauterbourg 26
Houston 25
Seattle 24
Moscow 23
Altamura 22
Lawrence 22
Mumbai 21
Turku 21
Council Bluffs 20
Cambridge 18
Kent 18
Wilmington 18
Frankfurt am Main 17
Princeton 17
Woodbridge 17
Melbourne 16
Rome 16
Boston 14
Jakarta 14
Tokyo 14
Bern 13
Shanghai 12
São Paulo 12
The Dalles 12
Dallas 11
Dnipro 11
Da Nang 10
Lappeenranta 10
Adapazarı 9
Bengaluru 9
London 9
San Diego 9
Ann Arbor 7
Chennai 7
Medford 7
Montreal 7
Phoenix 7
Stockholm 7
Düsseldorf 6
Hillsboro 6
Naples 6
Orem 6
Rio de Janeiro 6
Toronto 6
Abuja 5
Barnet 5
Chicago 5
Guangzhou 5
Haiphong 5
Mexico City 5
Abidjan 4
Atlanta 4
Barcelona 4
Brasília 4
Brooklyn 4
Denver 4
Manchester 4
Milan 4
Paris 4
Poplar 4
San Francisco 4
Shenzhen 4
West Jordan 4
Wroclaw 4
Yubileyny 4
Amsterdam 3
Boardman 3
Buenos Aires 3
Bắc Ninh 3
Campinas 3
Clifton 3
Cotonou 3
Dhaka 3
Johannesburg 3
Managua 3
Padua 3
Prato 3
Sobral 3
São Bernardo do Campo 3
Turin 3
Totale 3.099
Nome #
Clinical events beyond one year after an acute coronary syndrome: Insights from the RECLOSE 2-ACS study 339
Optimal timing of follow-up cardiac magnetic resonance in patients with uncomplicated acute myocarditis 229
Clinical staging of Anderson-Fabry cardiomyopathy: An operative proposal 206
Risk stratification using the CHA2DS2-VASc score in Takotsubo syndrome: Data from the Takotsubo Italian network 182
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany 177
Myocardial infarction with non-obstructive coronary arteries in hypertrophic cardiomyopathy vs Fabry disease 170
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring 169
Emerging Medical Treatment for Hypertrophic Cardiomyopathy 161
Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study 160
Relationship between hyponatremia at hospital admission and cardiopulmonary profile at follow-up in patients with SARS-CoV-2 (COVID-19) infection 159
Early Diagnosis and Outcome in Patients With Wild-Type Transthyretin Cardiac Amyloidosis 156
Clinical scenarios of HCM-related mortality: Relevance of age and stage of disease at presentation 155
Strength of clinical indication and therapeutic impact of the implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy 151
Cellular determinants of arrhythmic rysk in hypertrophic cardiomyopathy 149
Impact of Pregnancy on the Natural History of Women with Hypertrophic Cardiomyopathy 144
Decrease and Delay in Hospitalization for Acute Coronary Syndromes During the 2020 SARS-CoV-2 Pandemic 141
Prevalence and predictors of bradyarrhythmias requiring permanent pacing in patients with Anderson-Fabry disease 140
Prevalence and prognostic role of nonsustained ventricular tachycardia in cardiac amyloidosis 139
Assessing cardiac mechanics through left ventricular haemodynamic forces 137
Prevalence of Inherited Cardiac Diseases Among Young Patients Requiring Permanent Pacing 135
Incidence of light chain amyloidosis in Florence metropolitan area, Italy: a population-based study 133
Discriminatory ability of CHA2DS2-VASc score to predict residual platelet reactivity and outcomes in patients with acute coronary syndrome 131
Clinical course and outcome of pregnancy in patients with hypertrophic cardiomyopathy 129
Predicting Mortality Risk in Older Hospitalized Persons With COVID-19: A Comparison of the COVID-19 Mortality Risk Score with Frailty and Disability 124
Sex-related differences in clinical presentation and all-cause mortality in patients with cardiac transthyretin amyloidosis and light chain amyloidosis 122
Atlas of Regional Left Ventricular Scar in Nonischemic Cardiomyopathies: Substrates and Etiologies 119
Relation between post-myocardial infarct remodelling and gelatinase activity in patients enrolled in the TIPTOP trial 115
Myocarditis and COVID-19 related issues 113
Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy 101
Radiomics of Late Gadolinium Enhancement Reveals Prognostic Value of Myocardial Scar Heterogeneity in Hypertrophic Cardiomyopathy 100
Correction to: Clinical staging of Anderson‑Fabry cardiomyopathy: an operative proposal 91
SUDDEN DEATH RISK AMONG HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH LEFT VENTRICULAR APICAL ANEURYSMS: DOES SIZE MATTER? 87
Screening for dilated cardiomyopathy in immediate family members: to whom, how, when (and where) 26
Factors associated with persistent symptoms after COVID-19 infection: a longitudinal study on an Italian cohort of patients discharged from hospital 25
Factors associated with persistent symptoms after COVID-19 infection: a longitudinal study on an Italian cohort of patients discharged from hospital 21
Changes in CMR-derived ventricular strain, fibrosis progression and outcomes in hypertrophic cardiomyopathy 14
Cardiac involvement in Fabry disease: Recent advances, unresolved issues, and unmet needs 10
Totale 4.860
Categoria #
all - tutte 14.420
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.420


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202111 0 0 0 0 0 0 0 0 0 0 7 4
2021/2022134 10 1 7 0 2 7 0 12 19 9 27 40
2022/2023405 29 74 20 14 21 67 56 30 52 7 15 20
2023/2024234 5 22 24 11 17 31 14 55 6 19 21 9
2024/20251.673 36 139 74 241 342 212 47 81 193 55 95 158
2025/20262.132 225 311 278 268 235 79 235 93 171 145 92 0
Totale 4.860